 Kristy Crooks
Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pathology, Molecular | 2 | 2023 | 26 | 1.050 |
Why?
| | Counselors | 1 | 2023 | 11 | 0.880 |
Why?
| | Biological Specimen Banks | 4 | 2024 | 101 | 0.540 |
Why?
| | Genetic Testing | 6 | 2023 | 383 | 0.530 |
Why?
| | Glaucoma, Open-Angle | 3 | 2012 | 95 | 0.520 |
Why?
| | Precision Medicine | 5 | 2024 | 356 | 0.500 |
Why?
| | Pharmacogenetics | 3 | 2024 | 154 | 0.420 |
Why?
| | Genealogy and Heraldry | 1 | 2011 | 5 | 0.390 |
Why?
| | Pharmacogenomic Testing | 2 | 2022 | 54 | 0.370 |
Why?
| | Genetic Linkage | 1 | 2011 | 314 | 0.360 |
Why?
| | Genomics | 6 | 2024 | 653 | 0.350 |
Why?
| | Receptor, trkB | 1 | 2010 | 28 | 0.350 |
Why?
| | Dopamine Uptake Inhibitors | 1 | 2010 | 54 | 0.340 |
Why?
| | High-Throughput Nucleotide Sequencing | 4 | 2023 | 446 | 0.340 |
Why?
| | Space Perception | 1 | 2010 | 62 | 0.340 |
Why?
| | Behavior, Animal | 2 | 2010 | 472 | 0.340 |
Why?
| | Decision Support Systems, Clinical | 2 | 2024 | 180 | 0.340 |
Why?
| | Conditioning, Classical | 1 | 2010 | 86 | 0.340 |
Why?
| | Cytochrome P-450 CYP2C19 | 3 | 2024 | 25 | 0.330 |
Why?
| | Genome-Wide Association Study | 2 | 2012 | 1277 | 0.310 |
Why?
| | Cocaine | 1 | 2010 | 153 | 0.300 |
Why?
| | Exome | 4 | 2015 | 206 | 0.280 |
Why?
| | Cytochrome P-450 CYP2D6 | 2 | 2022 | 25 | 0.250 |
Why?
| | Thyroid Nodule | 1 | 2024 | 37 | 0.220 |
Why?
| | Germ Cells | 1 | 2023 | 62 | 0.220 |
Why?
| | Pathologists | 1 | 2021 | 15 | 0.190 |
Why?
| | Specimen Handling | 2 | 2021 | 157 | 0.190 |
Why?
| | Thyroid Neoplasms | 1 | 2024 | 262 | 0.180 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2024 | 400 | 0.180 |
Why?
| | Diagnosis | 1 | 2018 | 9 | 0.160 |
Why?
| | Genetic Variation | 3 | 2020 | 893 | 0.160 |
Why?
| | Fellowships and Scholarships | 1 | 2021 | 241 | 0.160 |
Why?
| | DNA Copy Number Variations | 1 | 2018 | 157 | 0.150 |
Why?
| | Incidental Findings | 2 | 2015 | 77 | 0.150 |
Why?
| | Education, Medical, Graduate | 1 | 2021 | 378 | 0.150 |
Why?
| | Data Collection | 1 | 2020 | 637 | 0.140 |
Why?
| | Academic Medical Centers | 1 | 2020 | 416 | 0.140 |
Why?
| | Genome, Human | 2 | 2015 | 372 | 0.140 |
Why?
| | Retinal Dystrophies | 1 | 2015 | 3 | 0.130 |
Why?
| | Humans | 23 | 2024 | 115859 | 0.130 |
Why?
| | Genetic Diseases, Inborn | 1 | 2015 | 37 | 0.130 |
Why?
| | Muscle Hypotonia | 1 | 2015 | 31 | 0.130 |
Why?
| | Curriculum | 1 | 2021 | 856 | 0.120 |
Why?
| | Medicare | 1 | 2020 | 666 | 0.120 |
Why?
| | Chromosomes, Human, Pair 8 | 2 | 2012 | 34 | 0.120 |
Why?
| | Mutation | 3 | 2018 | 3371 | 0.120 |
Why?
| | Biomedical Research | 1 | 2020 | 589 | 0.120 |
Why?
| | Carbidopa | 1 | 2014 | 4 | 0.120 |
Why?
| | GTP Cyclohydrolase | 1 | 2014 | 7 | 0.120 |
Why?
| | Spastic Paraplegia, Hereditary | 1 | 2014 | 6 | 0.120 |
Why?
| | Seizures | 2 | 2015 | 344 | 0.120 |
Why?
| | Levodopa | 1 | 2014 | 23 | 0.120 |
Why?
| | Dystonic Disorders | 1 | 2014 | 17 | 0.120 |
Why?
| | Dopamine Agonists | 1 | 2014 | 31 | 0.120 |
Why?
| | Ophthalmology | 1 | 2015 | 77 | 0.110 |
Why?
| | Abnormalities, Multiple | 1 | 2015 | 176 | 0.110 |
Why?
| | Exfoliation Syndrome | 1 | 2012 | 10 | 0.100 |
Why?
| | Nerve Degeneration | 1 | 2012 | 40 | 0.100 |
Why?
| | Adult | 11 | 2022 | 30814 | 0.100 |
Why?
| | Mutation, Missense | 2 | 2015 | 296 | 0.100 |
Why?
| | Chromosomes, Human, Pair 15 | 1 | 2011 | 53 | 0.100 |
Why?
| | DNA | 2 | 2015 | 1357 | 0.090 |
Why?
| | Managed Care Programs | 2 | 2022 | 135 | 0.090 |
Why?
| | PC12 Cells | 1 | 2010 | 37 | 0.090 |
Why?
| | Databases, Genetic | 1 | 2011 | 211 | 0.090 |
Why?
| | Nerve Growth Factors | 1 | 2010 | 73 | 0.090 |
Why?
| | Transforming Growth Factor beta | 1 | 2012 | 447 | 0.080 |
Why?
| | Nuclear Matrix-Associated Proteins | 1 | 2009 | 5 | 0.080 |
Why?
| | Distal Myopathies | 1 | 2009 | 6 | 0.080 |
Why?
| | Informed Consent | 2 | 2020 | 163 | 0.080 |
Why?
| | Nucleus Accumbens | 1 | 2010 | 123 | 0.080 |
Why?
| | Colorado | 3 | 2024 | 4122 | 0.080 |
Why?
| | Emergency Service, Hospital | 1 | 2018 | 1842 | 0.080 |
Why?
| | Genetic Predisposition to Disease | 1 | 2015 | 2201 | 0.070 |
Why?
| | Male | 10 | 2020 | 56103 | 0.070 |
Why?
| | RNA-Binding Proteins | 1 | 2009 | 363 | 0.070 |
Why?
| | Phosphorylation | 1 | 2010 | 1562 | 0.060 |
Why?
| | Female | 10 | 2020 | 60070 | 0.060 |
Why?
| | Mice, Transgenic | 1 | 2010 | 1971 | 0.060 |
Why?
| | Nerve Tissue Proteins | 1 | 2008 | 537 | 0.060 |
Why?
| | Age Factors | 1 | 2011 | 2911 | 0.060 |
Why?
| | Aged | 4 | 2020 | 19292 | 0.050 |
Why?
| | Alleles | 2 | 2018 | 817 | 0.050 |
Why?
| | Phenotype | 3 | 2015 | 2859 | 0.050 |
Why?
| | Middle Aged | 5 | 2018 | 27078 | 0.050 |
Why?
| | Genes, Dominant | 2 | 2015 | 93 | 0.050 |
Why?
| | Genome, Viral | 1 | 2022 | 121 | 0.050 |
Why?
| | Rats | 1 | 2010 | 5035 | 0.050 |
Why?
| | Sequence Analysis, DNA | 2 | 2015 | 737 | 0.050 |
Why?
| | Syndrome | 2 | 2015 | 339 | 0.050 |
Why?
| | Heterozygote | 2 | 2014 | 254 | 0.050 |
Why?
| | Pedigree | 2 | 2015 | 474 | 0.050 |
Why?
| | Consent Forms | 1 | 2020 | 12 | 0.050 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2015 | 2004 | 0.050 |
Why?
| | Antidepressive Agents | 1 | 2022 | 195 | 0.050 |
Why?
| | Vitamin K Epoxide Reductases | 1 | 2020 | 12 | 0.050 |
Why?
| | Aged, 80 and over | 1 | 2011 | 6434 | 0.040 |
Why?
| | Ultrasonography | 1 | 2024 | 669 | 0.040 |
Why?
| | Time Factors | 1 | 2010 | 6182 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2024 | 1725 | 0.040 |
Why?
| | Genotype | 1 | 2024 | 1830 | 0.040 |
Why?
| | Phylogeny | 1 | 2022 | 806 | 0.040 |
Why?
| | Amino Acid Substitution | 2 | 2010 | 267 | 0.040 |
Why?
| | Surveys and Questionnaires | 2 | 2020 | 4673 | 0.040 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2024 | 862 | 0.040 |
Why?
| | Workflow | 1 | 2018 | 138 | 0.040 |
Why?
| | Electronic Health Records | 1 | 2024 | 805 | 0.040 |
Why?
| | Signal Transduction | 1 | 2010 | 4527 | 0.040 |
Why?
| | Mice | 2 | 2010 | 15085 | 0.030 |
Why?
| | Phosphotransferases | 1 | 2015 | 25 | 0.030 |
Why?
| | Child | 3 | 2020 | 18537 | 0.030 |
Why?
| | Computational Biology | 1 | 2018 | 540 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 2015 | 505 | 0.030 |
Why?
| | Codon, Nonsense | 1 | 2014 | 38 | 0.030 |
Why?
| | Depression | 1 | 2022 | 1145 | 0.030 |
Why?
| | Gene Frequency | 1 | 2015 | 506 | 0.030 |
Why?
| | Child, Preschool | 2 | 2018 | 9164 | 0.030 |
Why?
| | Drug Combinations | 1 | 2014 | 289 | 0.030 |
Why?
| | Genetic Association Studies | 1 | 2015 | 352 | 0.030 |
Why?
| | Cardiovascular Diseases | 1 | 2024 | 1724 | 0.030 |
Why?
| | Chromosomes, Human, Pair 9 | 1 | 2012 | 43 | 0.030 |
Why?
| | Optic Nerve | 1 | 2012 | 65 | 0.030 |
Why?
| | Animals | 2 | 2010 | 32158 | 0.020 |
Why?
| | RNA, Untranslated | 1 | 2012 | 114 | 0.020 |
Why?
| | RNA, Long Noncoding | 1 | 2012 | 158 | 0.020 |
Why?
| | Bulgaria | 1 | 2009 | 1 | 0.020 |
Why?
| | Nuclear Matrix | 1 | 2009 | 5 | 0.020 |
Why?
| | Dysphonia | 1 | 2009 | 11 | 0.020 |
Why?
| | Adolescent | 2 | 2018 | 17935 | 0.020 |
Why?
| | Homeodomain Proteins | 1 | 2012 | 465 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2009 | 353 | 0.020 |
Why?
| | Blotting, Northern | 1 | 2008 | 194 | 0.020 |
Why?
| | Maze Learning | 1 | 2008 | 87 | 0.020 |
Why?
| | Electroshock | 1 | 2008 | 140 | 0.020 |
Why?
| | Gene Targeting | 1 | 2008 | 77 | 0.020 |
Why?
| | Reflex, Startle | 1 | 2008 | 58 | 0.020 |
Why?
| | Deglutition Disorders | 1 | 2009 | 119 | 0.020 |
Why?
| | Age of Onset | 1 | 2009 | 455 | 0.020 |
Why?
| | Food Preferences | 1 | 2008 | 108 | 0.020 |
Why?
| | Amygdala | 1 | 2008 | 179 | 0.020 |
Why?
| | Memory | 1 | 2008 | 211 | 0.020 |
Why?
| | Social Environment | 1 | 2008 | 287 | 0.020 |
Why?
| | Cerebellum | 1 | 2008 | 200 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 935 | 0.020 |
Why?
| | Fear | 1 | 2008 | 296 | 0.020 |
Why?
| | Base Sequence | 1 | 2009 | 2121 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2009 | 2003 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2009 | 2796 | 0.010 |
Why?
| | Hippocampus | 1 | 2008 | 709 | 0.010 |
Why?
| | United States | 1 | 2020 | 12319 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2020 | 12615 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2010 | 3054 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2008 | 2608 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2014 | 9163 | 0.010 |
Why?
| | Young Adult | 1 | 2015 | 10508 | 0.010 |
Why?
| | Muscle, Skeletal | 1 | 2009 | 1459 | 0.010 |
Why?
|
|
Crooks's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|